Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus
Top Cited Papers
- 1 January 2000
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 22, B101-B121
- https://doi.org/10.1016/s0149-2918(00)89027-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- An immunoassay for the measurement of sirolimusClinical Therapeutics, 2000
- SIROLIMUS REDUCES THE INCIDENCE OF ACUTE REJECTION EPISODES DESPITE LOWER CYCLOSPORINE DOSES IN CAUCASIAN RECIPIENTS OF MISMATCHED PRIMARY RENAL ALLOGRAFTS: A PHASE II TRIAL1Transplantation, 1999
- SAFETY AND PHARMACOKINETIC PROFILE OF ASCENDING SINGLE DOSES OF ORAL LIQUID SIROLIMUS (Rapamycin) IN PEDIATRIC PATIENTS WITH STABLE CHRONIC RENAL FAILURE.Transplantation, 1999
- SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATIONTransplantation, 1999
- Pharmacokinetics of Prednisolone During Administration of Sirolimus in Patients with Renal TransplantsThe Journal of Clinical Pharmacology, 1996
- IMMUNOPHARMACOLOGY OF RAPAMYCINAnnual Review of Immunology, 1996
- PREDICTING GLOMERULAR FILTRATION RATE AFTER KIDNEY TRANSPLANTATIONTransplantation, 1995
- Blood Distribution Of RapamycinTransplantation, 1993
- Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activityBiochemistry, 1992
- Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.The Journal of Antibiotics, 1975